ALLERGIOS

"We see Allergy": Direct allergy diagnostics by lable-free visualisition of the patients allergic response. Allergios is developing an AI-powered microfluidic platform for functional allergy diagnostics, aiming to replace risky and resource-intensive oral provocation tests (e.g., DBPCFC) with a cell-based blood test that analyzes individual immune responses to allergens. The platform combines digital holography, cellular immunoassays, and machine learning, targeting a fast-growing global diagnostics market.